ID

12962

Description

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193037

Lien

https://clinicaltrials.gov/show/NCT00193037

Mots-clés

  1. 07/01/2016 07/01/2016 -
Téléchargé le

7 janvier 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00193037

Eligibility Breast Cancer NCT00193037

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
metastatic breast cancer confirmed by biopsy
Description

biopsy metastasis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C0027627
prior adjuvant/neoadjuvant treatment allowed
Description

therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
measurable disease
Description

measurable disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
able to perform activities of daily living with minimal assistance
Description

performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1518965
age 18 years or older
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
adequate bone marrow, liver and kidney function
Description

bone marrow, liver and kidney function

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0005953
UMLS CUI [3]
C0232804
normal heart function
Description

heart

Type de données

boolean

Alias
UMLS CUI [1]
C0018787
written informed consent
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pre-existing moderate peripheral neuropathy
Description

peripheral neuropathy

Type de données

boolean

Alias
UMLS CUI [1]
C0031117
history of significant heart disease
Description

heart disease

Type de données

boolean

Alias
UMLS CUI [1]
C0018799
meningeal metastases.
Description

meningeal metastases

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0025284
prior chemotherapy for metastatic breast cancer
Description

chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
no measurable disease (including bone only, pleural effusions, etc.)
Description

measurable disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
receiving herceptin therapy.
Description

herceptin

Type de données

boolean

Alias
UMLS CUI [1]
C0338204
women who are pregnant or lactating.
Description

pregnancy, lactation

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

additional inclusion/exclusion criteria

Type de données

boolean

Similar models

Eligibility Breast Cancer NCT00193037

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
biopsy metastasis
Item
metastatic breast cancer confirmed by biopsy
boolean
C0005558 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
therapy
Item
prior adjuvant/neoadjuvant treatment allowed
boolean
C0087111 (UMLS CUI [1])
measurable disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
performance status
Item
able to perform activities of daily living with minimal assistance
boolean
C1518965 (UMLS CUI [1])
age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
heart
Item
normal heart function
boolean
C0018787 (UMLS CUI [1])
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
peripheral neuropathy
Item
pre-existing moderate peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
heart disease
Item
history of significant heart disease
boolean
C0018799 (UMLS CUI [1])
meningeal metastases
Item
meningeal metastases.
boolean
C0027627 (UMLS CUI [1,1])
C0025284 (UMLS CUI [1,2])
chemotherapy
Item
prior chemotherapy for metastatic breast cancer
boolean
C0392920 (UMLS CUI [1])
measurable disease
Item
no measurable disease (including bone only, pleural effusions, etc.)
boolean
C1513041 (UMLS CUI [1])
herceptin
Item
receiving herceptin therapy.
boolean
C0338204 (UMLS CUI [1])
pregnancy, lactation
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
additional inclusion/exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial